14158 Results (Page 447 of 567)
All Market Research Reports
Poland Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Poland infectious disease therapeutics market will reach a value of $1012 Mn from $695 Mn in 2022, growing at a CAGR of 4.8% during 2022-2030. Infectious Disease Therapeutics in Poland is dominated by a few domestic pharmaceutical companies such as Polpharma Group, Selvita and Adamed Group. The Infectious Disease Therapeutics market in Poland is segmented into different therapeutic areas and different diseases type. The major factors affecting the Poland infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, COVID-19, and the amount of healthcare funding for infectious diseases treatment in various areas of Poland.
China Teleradiology Market Analysis
The China Teleradiology market size was valued at $191 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 12.20% from 2022 to 2030 and will reach $ 514 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The China teleradiology market will grow due to Increasing demand for remote radiology services. The key market players are United Imaging Healthcare (UIH), AliHealth, Nanjing Remote Medical Imaging (NRMI), Beijing Deepwise & League of PHD Technology (DL), Yitu Healthcare, and others.
Philippines Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Philippines infectious disease therapeutics market will reach a value of $385.2 Mn from $263.71 Mn in 2022, growing at a CAGR of 4.9% during 2022-2030. The Infectious Disease Therapeutics in the Philippines is dominated by a few domestic pharmaceutical companies such as Glovax Biotech, United Laboratories and Pharex Health Corporation. The Infectious Disease Therapeutics market in the Philippines is segmented into different therapeutic areas and different diseases type. The major factors affecting the Philippines' infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of the Philippines.
Nigeria Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Nigeria infectious disease therapeutics market will reach a value of $163.7 Mn from $107.9 Mn in 2022, growing at a CAGR of 5.4% during 2022-2030. The Infectious Disease Therapeutics in Nigeria is dominated by a few domestic pharmaceutical companies such as Fidson Healthcare, Emzor Pharmaceutical and Afrigen Biologics. The Infectious Disease Therapeutics market in Nigeria is segmented into different therapeutic areas and different diseases type. The major factors affecting the Nigeria infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, COVID-19, and the amount of healthcare funding for infectious diseases treatment in various areas of Nigeria.
Mexico Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Mexico infectious disease therapeutics market will reach a value of $2.58 Bn from $1.8 Bn in 2022, growing at a CAGR of 4.6% during 2022-2030. Infectious Disease Therapeutics in Mexico is dominated by a few domestic pharmaceutical companies such as Silanes Laboratories, BIRMEX and Liomont Laboratories. The Infectious Disease Therapeutics market in Mexico is segmented into different therapeutic areas and different diseases type. The major factors affecting the Mexico infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various areas of Mexico.
Malaysia Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Malaysia infectious disease therapeutics market will reach a value of $275.12 Mn from $192.72 Mn in 2022, growing at a CAGR of 4.6% during 2022-2030. Infectious Disease Therapeutics in Malaysia is dominated by a few domestic pharmaceutical companies such as Pharmaniaga Berhad, Duopharma Biotech and Kotra Pharma. The Infectious Disease Therapeutics market in Malaysia is segmented into different therapeutic areas and different diseases type. The major factors affecting the Malaysia infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of Malaysia.
China Alzheimer’s Disease Drugs Market Analysis
The China Alzheimer’s Disease Drugs market was valued at $1.24 Bn in 2022 and is estimated to expand at a CAGR of 9.42% from 2022-30 and will reach $2.64 Bn in 2030. One of the main reasons propelling the growth of this market is government support, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Shanghai Green Valley Pharmaceutica, Eisai Co., Eli Lilly and Company, H. Lundbeck A/S, Johnson and Johnson, Hengrui Medicine Co, Jiangsu Hengrui, Novartis AG, Chongqing Zhifei Biological Products, Pfizer and CSPC Pharmaceutical Group among others.
Japan Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Japan infectious disease therapeutics market will reach a value of $10.88 Bn from $7.45 Bn in 2022, growing at a CAGR of 4.9% during 2022-2030. Infectious Disease Therapeutics in Japan is dominated by a few domestic pharmaceutical companies such as Astellas Pharma, Daiichi Sankyo and Takeda Pharmaceutical. The Infectious Disease Therapeutics market in Japan is segmented into different therapeutic areas and different diseases type. The major factors affecting the Japanese infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of Japan.
Brazil Teleradiology Market Analysis
The Brazil Teleradiology market size was valued at $59 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 12.7% from 2022 to 2030 and will reach $ 154 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Brazil teleradiology market will grow due to Increasing demand for remote radiology services. The key market players are Telelaudo, Imex Medical Group, CMB Diagnósticos, Telemedicina Brasil, Medcloud, Telerrad, ONRAD, Telerradiologia do Brasil, Smart, Teleradiologia, Clínica Radiológica da Mulher.and others.
Canada Teleradiology Market Analysis
The Canada Teleradiology market size was valued at $190 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 11.7% from 2022 to 2030 and will reach $ 459 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Canada teleradiology market will grow due to Increasing demand for remote radiology services. The key market players are Radiology Consultants Associated (RCA), NightHawk Radiology Services, Calgary Scientific, and others.
Italy Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Italy infectious disease therapeutics market will reach a value of $3.89 Bn from $2.88 Bn in 2022, growing at a CAGR of 3.9% during 2022-2030. Infectious Disease Therapeutics in Italy is dominated by a few domestic pharmaceutical companies such as Menarini, Dompé and IRBM. The infectious disease therapeutics market in Italy is segmented into different therapeutic areas and different treatment types. The major factors affecting the Italy infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various areas of Italy.
Africa Alzheimer’s Disease Drugs Market
The Africa Alzheimer’s Disease Drugs market was valued at $231 Mn in 2022 and is estimated to expand at a CAGR of 9.92% from 2022-30 and will reach $493 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are AbbVie, AstraZeneca, Biogen, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, and Pfizer among others.
US Teleradiology Market Analysis
The US Teleradiology market size was valued at $995 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.7% from 2022 to 2030 and will reach $2088 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The US teleradiology market will grow due to technological advancements in cloud computing telecommunication and image transfer technologies have made it easier to transmit radiological images remotely. The key market players are vRad, Radiology Partners, Nighthawk Radiology Services, and others.
Indonesia Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Indonesia infectious disease therapeutics market will reach a value of $1011 Mn from $719.22 Mn in 2022, growing at a CAGR of 4.4% during 2022-2030. Infectious Disease Therapeutics in Indonesia is dominated by a few domestic pharmaceutical companies such as Pharos Indonesia, Bio Farma and Kalbe Farma. The Infectious Disease Therapeutics market in Indonesia is segmented into different therapeutic areas and different diseases type. The major factors affecting the Indonesia infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of Indonesia.
Germany Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the German infectious disease therapeutics market will reach a value of $5.37 Bn from $4.39 Bn in 2022, growing at a CAGR of 2.6% during 2022-2030. Infectious Disease Therapeutics in Germany is dominated by a few domestic pharmaceutical companies such as BioNTech, Evotec and InfectoPharm. The Infectious Disease Therapeutics market in Germany is segmented into different therapeutic areas and different diseases type. The major factors affecting the German infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the lack of healthcare funding for infectious disease treatment in various areas of Germany.
Australia Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Australia infectious disease therapeutics market will reach a value of $2.27 Bn from $1.44 Bn in 2022, growing at a CAGR of 5.9% during 2022-2030. Infectious Disease Therapeutics in Australia is dominated by domestic pharmaceutical companies such as AdAlta, Starpharma and CSL. The Infectious Disease Therapeutics market in Australia is segmented into different therapeutic areas and different diseases type. The major factors affecting the Australia infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various of areas of Australia.
Brazil Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Brazil infectious disease therapeutics market will reach a value of $4.5 Bn from $3.1 Bn in 2022, growing at a CAGR of 5.4% during 2022-2030. Infectious Disease Therapeutics in Brazil is dominated by a few domestic pharmaceutical companies such as Cristália, Fiocruz and Eurofarma. The Infectious Disease Therapeutics market in Brazil is segmented into different therapeutic areas and different diseases type. The major factors affecting the Brazil infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various areas of Brazil.
China Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the China infectious disease therapeutics market will reach a value of $15.19 Bn from $9.64 Bn in 2022, growing at a CAGR of 5.9% during 2022-2030. Infectious Disease Therapeutics in China is dominated by a few domestic pharmaceutical companies such as WuXi Biologics, Fosun Pharma and CanSino Biologics. The infectious disease therapeutics market in China is segmented into different therapeutic areas and different treatment types. The major factors affecting the China infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various areas of China.
Egypt Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt infectious disease therapeutics market will reach a value of $528.93 Mn from $335.64 Mn in 2022, growing at a CAGR of 5.9% during 2022-2030. The Infectious Disease Therapeutics in Egypt is dominated by a few domestic pharmaceutical companies such as EIPICO, Pharco Pharmaceuticals and Memphis Pharmaceutical. The Infectious Disease Therapeutics market in Egypt is segmented into different therapeutic areas and different diseases type. The major factors affecting the Egypt infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various of areas of Egypt.
UK Clinical Diagnostics Market Analysis
The UK Clinical Diagnostic market was valued at $1.79 Bn in 2022 and is estimated to expand at a CAGR of 4% from 2022-30 and will reach $2.45 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, Omega Diagnostics, Quest Diagnostics, F. Hoffmann-La Roche, LumiraDx, Diagnostics.ai, Thermo Fisher Scientific, Danaher Corporation, and others.
France Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the France infectious disease therapeutics market will reach a value of $4.29 Bn from $3.3 Bn in 2022, growing at a CAGR of 3.4% during 2022-2030. The Infectious Disease Therapeutics in France is dominated by a few domestic pharmaceutical companies such as BioMérieux, Sanofi and Institut Mérieux. The Infectious Disease Therapeutics market in France is segmented into different therapeutic areas and different diseases type. The major factors affecting the France infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the lack of healthcare funding for infectious diseases treatment in various areas of France.
Germany Clinical Diagnostics Market Analysis
Germany's clinical diagnostic market was valued at $2.52 Bn in 2022 and is estimated to expand at a CAGR of 4.2% from 2022-30 and will reach $3.50 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Merck and others.
China Clinical Diagnostics Market Analysis
China's clinical diagnostic market was valued at $5.5 Bn in 2022 and is estimated to expand at a CAGR of 7.5% from 2022-30 and will reach $9.9 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Sysmex, Mindray, Shanghai Fosun Pharmaceutical Group, Guangzhou Wondfo Biotech, Beijing Leadman Biochemistry Co. and others.
Australia Clinical Diagnostics Market Analysis
Australia's clinical diagnostic market was valued at $827 Mn in 2022 and is estimated to expand at a CAGR of 7.5% from 2022 to 2030 and will reach $1475 Mn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, Australian Clinical Labs, Healthscope Limited, Primary Health Care Limited, Sonic Healthcare, Healius, Austech Medical Laboratories, I-Med Radiology Network, and others.
APAC Alzheimer’s Disease Drugs Market
The APAC Alzheimer’s Disease Drugs market was valued at $3.24 Bn in 2022 and is estimated to expand at a CAGR of 9.69% from 2022-30 and will reach $6.79 Bn in 2030. One of the main reasons propelling the growth of this market is government initiatives and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Eisai Co., Daiichi Sankyo Company, Pfizer, Novartis International AG, H Lundbeck A/S, and Merck & Co., among others.
